CurrentRheuma
Get Weekly

Topic · page 11 of 11

Inflammatory myopathies

Dermatomyositis, polymyositis, antisynthetase syndrome, immune-mediated necrotizing myopathy, inclusion body myositis, myositis-specific antibodies, myositis-associated interstitial lung disease and cancer-associated myositis

Briefs 401–430 of 430 placed here, newest publication first

Briefs in Inflammatory myopathies

Newest publication first

  1. Ann Rheum Dis

    Low copy numbers of complement C4 and C4A deficiency are risk factors for myositis, its subgroups and autoantibodies

    Case-control study

  2. Rheumatology (Oxford)

    Longitudinal study of patients with antimelanoma differentiation-associated gene 5 antibody-positive dermatomyositis-associated interstitial lung disease

    Cohort study

  3. Rheumatology (Oxford)

    Eosinophilic fasciitis (Shulman syndrome)—recognition of the histological spectrum allows for new insights into possible pathomechanisms

    Mechanistic study

  4. Clin Exp Rheumatol

    Potential role of type I interferon/IP-10 axis in the pathogenesis of anti-MDA5 antibody-positive dermatomyositis

    Mechanistic study

  5. J Rheumatol

    A Systematic Review and Metaanalysis of Predictors of Mortality in Idiopathic Inflammatory Myopathy–Associated Interstitial Lung Disease

    Meta-analysis

  6. Arthritis Care Res (Hoboken)

    Comparison of Patient‐Reported Outcomes Measurement Information System Computerized Adaptive Testing Versus Fixed Short Forms in Juvenile Myositis

    Cross-sectional study

  7. Ann Rheum Dis

    Coexisting autoantibodies against transcription factor Sp4 are associated with decreased cancer risk in patients with dermatomyositis with anti-TIF1γ autoantibodies

    Cross-sectional study

  8. Rheumatology (Oxford)

    Time-dependent changes in RPILD and mortality risk in anti-MDA5+ DM patients: a cohort study of 272 cases in China

    Cohort study

  9. Rheumatology (Oxford)

    Anti-FHL1 autoantibodies in juvenile myositis are associated with anti-Ro52 autoantibodies but not with severe disease features

    Cross-sectional study

  10. Rheumatology (Oxford)

    Low-dose rituximab is efficacious in refractory idiopathic inflammatory myopathies

    Cohort study

  11. Rheumatology (Oxford)

    Experience with the use of mycophenolate mofetil in juvenile idiopathic inflammatory myopathies

    Cohort study

  12. Rheumatology (Oxford)

    Impaired physical function in patients with idiopathic inflammatory myopathies: results from the multicentre COVAD patient-reported e-survey

    Cross-sectional study

  13. Clin Exp Rheumatol

    The role of magnetic resonance imaging in the diagnostic work-out of myopathies: differential diagnosis between inflammatory myopathies and muscular dystrophies

    Diagnostic or prognostic study

  14. Rheumatology (Oxford)

    Evaluating the value of superoxide dismutase in anti-MDA5-positive dermatomyositis associated with interstitial lung disease

    Cohort study

  15. Rheumatology (Oxford)

    Longitudinal changes in nailfold videocapillaroscopy findings differ by myositis-specific autoantibody in idiopathic inflammatory myopathy

    Cohort study

  16. Rheumatology (Oxford)

    Work situation, work ability and expectation of returning to work in patients with systemic autoimmune myopathies

    Cross-sectional study

  17. Clin Exp Rheumatol

    Current status of clinical outcome measures in inclusion body myositis: a systematised review

    Research article

  18. Rheumatology (Oxford)

    Peripheral expansion of myeloid-derived suppressor cells is related to disease activity and damage accrual in inflammatory myopathies

    Cross-sectional study

  19. Rheumatology (Oxford)

    Accuracy of power Doppler ultrasonography in the diagnosis and monitoring of idiopathic inflammatory myopathies

    Diagnostic or prognostic study

  20. J Rheumatol

    Coexistence of Anti-Ro52 Antibodies in Anti-MDA5 Antibody–Positive Dermatomyositis Is Highly Associated With Rapidly Progressive Interstitial Lung Disease and Mortality Risk

    Cohort study

  21. Clin Exp Rheumatol

    Increased serum levels of sCD40L were associated with rapidly progressive interstitial lung disease in idiopathic inflammatory myopathies

    Cohort study

  22. Clin Exp Rheumatol

    In-patient comorbidities in inclusion body myositis: a United States national in-patient sample-based study

    Cohort study

  23. Rheumatology (Oxford)

    Adipose tissue distribution is associated with cardio-metabolic alterations in adult patients with juvenile-onset dermatomyositis

    Cross-sectional study

  24. Clin Exp Rheumatol

    Interstitial lung disease in adult patients with anti-NXP2 antibody positivity: a multicentre 18-month follow-up study

    Cohort study

  25. Clin Exp Rheumatol

    Use of Janus kinase inhibitors in dermatomyositis: a systematic literature review

    Research article

  26. Clin Exp Rheumatol

    The effect of COVID-19 pandemic on idiopathic inflammatory myositis patients: a single centre experience

    Cross-sectional study

  27. Clin Exp Rheumatol

    Association of the serum IgG glycosylation with disease activity of anti-transcription intermediary factor 1 gamma positive dermatomyositis

    Cross-sectional study

  28. Clin Exp Rheumatol

    High prevalence of necrotising myopathy pattern in muscle biopsies of patients with anti-Jo-1 antisynthetase syndrome

    Cross-sectional study

  29. Scand J Rheumatol

    Efficacy and safety of plasma exchange in interstitial lung diseases with anti-melanoma differentiation-associated 5 gene antibody positive clinically amyopathic dermatomyositis

    Case-control study

  30. Clin Exp Rheumatol

    Transcranial direct current stimulation is safe and effective in autoimmune myopathies: a randomised, double-blind, sham-controlled trial

    Randomized controlled trial

All 430 Briefs in ExploreShowing Briefs 401–430 of 430, newest first